However, there are no overlapping genes between our results and the gene signature identified by gene expression profiling of CD44+CD24- breast cancer stem-like cells [46]; therefore, our findings should be validated in further studies, for example, analysis of stem cell marker expression. This evidence concerns the gene CD44 and breast cancer.